High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration (FDA) later this month.

A substantial number of US dementia cases could be eliminated by mitigating modifiable cardiometabolic risk factors.

HealthDay News — A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published online June 2 in the Journal of ...

The US Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

A glaucoma diagnosis may increase a patient’s levels of anxiety, and depression, decreasing overall mental health scores.

Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

US Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he may no longer allow government scientists to publish research in top medical journals.

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

A study shows the ways in which brolucizumab can provide superior AMD therapy to some patients compared with aflibercept.

Direct selective laser trabeculoplasty is not yet noninferior to SLT in lowering IOP, but secondary endpoints show promise.